Alle Fälle anzeigen
UPC APP 16306/2025
—·EP4183412: RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieRücknahmeanträge
- Parteien
- KlägerVertreter: Oliver Jan Jüngst (Bird & Bird LLP); Luca Brons (Bird & Bird LLP); Daniela Kinkeldey (Bird & Bird LLP); Anna Schadel (Bird & Bird LLP)Beklagte
- Pfizer Europe MA EEIG
- Pfizer Manufacturing Belgium NV
- Pfizer Pharma GmbH
- Pfizer Corporation Austria GmbH
- Pfizer S.A.
- Pfizer Aps
- Pfizer Oy
- Pfizer SAS
- Pfizer S.r.l.
- Pfizer B.V.
- Laboratórios Pfizer, Lda.
- Pfizer AB
- Pfizer Luxembourg S.a.r.l.
- Pfizer Service Company S.R.L.
Vertreter: Gareth Williams (Marks & Clerk LLP); Claudia Milbradt (Clifford Chance); Tobias J. Hessel (Clifford Chance) - Division
- Dusseldorf LD
- Richter
- Jule Schumacher · Judge-Rapporteur / Legally Qualified Judge
- Andrea Postiglione · Legally Qualified Judge
- Steen Wadskov-Hansen · Technically Qualified Judge
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 11. Apr. 2025
Entscheidungen
- 2025-04-11ZurückgenommenApplication Rop 265
The Düsseldorf Local Division allowed GlaxoSmithKline Biologicals SA's withdrawal of its infringement action against Pfizer entities concerning EP 4 183 412 with the consent of all defendants, declared the proceedings closed, and ordered reimbursement of 60% of court fees amounting to EUR 201,600.
Rechtsfragen:Withdrawal of infringement action (R. 265.1 RoP)Reimbursement of court fees (R. 370 RoP)
Dokumente
- 2EB3BC86B1C2E383E6DDA311770590D1_en.pdf2025-04-11EN